These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24026753)

  • 1. Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.
    Sarlon J; Hess E; Krasnianski A
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E69-70. PubMed ID: 24026753
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproate-induced hyperammonemic encephalopathy: a case report and brief review of the literature.
    Sunkavalli KK; Iqbal FM; Singh B; Koneru J
    Am J Ther; 2013; 20(5):569-71. PubMed ID: 21248614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced hyperammonemic encephalopathy.
    Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
    Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Valproate-induced hyperammonemic encephalopathy].
    Granel B; Gavaret M; Le Baut X; Sautereau N; Rodriguez D; Rossi P; Bagnères D; Demoux AL; Francès Y
    Rev Med Interne; 2011 Jun; 32(6):e72-5. PubMed ID: 20633966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproate-induced hyperammonemic encephalopathy].
    Diaz-Rangel M; Grande-Martin A; Monsalve-Naharro JA; Domingo-Chiva E; Cuesta-Montero P; Lopez-Perez A
    Rev Neurol; 2017 Dec; 65(12):574-575. PubMed ID: 29235622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-induced hyperammonemic encephalopathy.
    Murphy JV
    Epilepsia; 2003 Feb; 44(2):268; author reply 268. PubMed ID: 12558587
    [No Abstract]   [Full Text] [Related]  

  • 10. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-induced encephalopathy in a comorbid elderly woman.
    Gandolfo F; Parodi MN; Corsini GP; Odetti P; Serafini G; Monacelli F
    Psychogeriatrics; 2017 May; 17(3):208-209. PubMed ID: 28093879
    [No Abstract]   [Full Text] [Related]  

  • 12. Valproate-induced Hyperammonemic Encephalopathy Presenting as Catatonia.
    Pérez-Esparza R; Oñate-Cadena N; Ramírez-Bermúdez J; Espínola-Nadurille M
    Neurologist; 2018 Mar; 23(2):51-52. PubMed ID: 29494435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of valproate-induced hyperammonaemic encephalopathy.
    Lucie O; Nazir F; Spilg E
    Scott Med J; 2013 Feb; 58(1):e43-4. PubMed ID: 23596040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammoneic encephalopathy, valproic acid, and benzodiazepine withdrawal: a case series.
    Starer J; Chang G
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):98-101. PubMed ID: 20337505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
    Deutsch SI; Burket JA; Rosse RB
    Clin Neuropharmacol; 2009; 32(6):350-2. PubMed ID: 19952878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.